CytoReason

CytoReason is a computational biology company based in Tel Aviv, Israel, founded in 2016. The company specializes in AI-driven disease modeling for the pharmaceutical and biotech industries. CytoReason develops proprietary computational models that simulate human diseases at a cellular level, bridging the gap between extensive molecular data and traditional analytical methods. The company's core offerings include computational disease models that integrate various molecular data types to map disease mechanisms. This technology supports target prioritization, biomarker discovery, combination therapy profiling, and clinical trial optimization, ultimately aiming to reduce costs and enhance drug approval success rates. CytoReason collaborates with top pharmaceutical companies, utilizing proprietary datasets to refine its models and adapt to new research areas. With a total funding of $20 million, CytoReason has attracted notable investors, including Pfizer and PICO Partners. The company continues to grow and expand its disease model library through ongoing collaborations, focusing on data-driven approaches to drug development.

Research Tel Aviv-Yafo, Israel ~116 employees Private · Series B

Work at CytoReason in HR or recruiting? Claim this page

Employees
116
0% in the 3 months to Sep 2026
Revenue / employee
$17.2K
Revenue ~$2M
Total funding
$130M
Last round Series B, Jul 2024
12-month attrition
11.6%
Tech: 13.9%
H1B sponsor
NA

Headcount trend

CytoReason went from 127 employees in Oct 2024 to 116 in Sep 2026. Apr to Sep 2026: 2 people joined, 5 left.

Funding rounds

Total funding$130M
Funding rounds3
Investors4
DateRoundMoney raisedNo.Investors
Jul 2024Series B$80M4
Sep 2022Funding$20M1
Jun 2021Funding$30M––

Org structure

Headcount by department

Other63
Engineering19
Operations12
Product6
Finance5
Sales5
HR4
Design2

CytoReason FAQ

How many employees does CytoReason have?

CytoReason has about 116 employees, unchanged over the 3 months to Sep 2026.

What is CytoReason's revenue per employee?

CytoReason makes about $17K in revenue per employee, based on $2M annual revenue and 116 employees.

How much funding has CytoReason raised?

CytoReason has raised $130M in total funding; its latest round was Series B in Jul 2024.

Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.